Farletuzumab

Tax included
Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer.
MedChemExpress 
HY-P99153

Data sheet

Size
Multiple sizes
Reactivity
Antibiotic
Application
Cancer-Kinase/protease
CAS
896723-44-7